Search the Newsreel

LyondellBasell (LYB) Q2 Earnings and Revenues Surpass Estimates

LyondellBasell (LYB) came out with quarterly earnings of $4.3 per share, beating the Zacks Consensus Estimate of $3.56 per share. This compares to earnings of $0.62 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Responsive Playbooks and the LYB Inflection

This article analyzes Lyondellbasell Industries Nv Class A (NYSE: LYB), noting a weak near-term sentiment that could precede shifts in its mid and long-term outlook. It identifies a mid-channel oscillation pattern and presents an exceptional 68.2:1 risk-reward setup, targeting a 19.2% gain with minimal …

LyondellBasell reports second quarter 2026 earnings

LyondellBasell Net income: $0.6 billion, $1.4 billion excluding identified items1 Diluted earnings per share: $1.71 per share; $4.30 per share excluding identified items EBITDA: $1.3 billion, $2.1 billion excluding identified items Strengthened the portfolio through the divestiture of select European assets, structurally improving the …

CENTURYPLY: Record revenue and profit growth with margin expansion across key segments

Rallybio Corp (RLYB) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Rallybio Corp (RLYB), noting its current valuation score of 6.53 within the Biotechnology & Medical Research industry. It highlights the company's P/E ratio of -11.68 and indicates that relevant data for P/B, P/S, and P/CF ratios have …

Rallybio Q1 2026 Earnings: Wider-than-Expected Loss as Development Costs Persist - Geographic Revenue Trends

LYB Set to Report Q2 Earnings: Here's What Investors Should Expect

LyondellBasell Industries N.V. LYB is set to release second-quarter 2026 results before the opening bell on Friday. LyondellBasell missed the Zacks Consensus Estimate for earnings in two of the trailing four quarters, and beat it twice, with the average negative earnings surprise being 47.2%. …

Rallybio (RLYB) to Release Quarterly Earnings on Thursday

Rallybio Corp (RLYB) Balance Sheet

This article provides a detailed balance sheet for Rallybio Corp (RLYB), offering quarterly and annual financial data spanning several years. It includes key financial metrics such as cash and investments, total assets, liabilities, and shareholders' equity, along with year-over-year changes. The report also features …

Chemical Marketing & Economics honors LyondellBasell CEO Peter Vanacker with STEM Leadership Award for Corporate Reinvention

LyondellBasell LyondellBasell (LYB) CEO Peter VanackerPeter Vanacker is chief executive officer of LyondellBasell, a global leader in the chemical industry delivering solutions for everyday sustainable living. HOUSTON and MORRISTOWN, N.J., July 28, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) and Chemical Marketing & Economics, …

RLYB|Rallybio Corp|Price:16.065|Chg%:-0.245

This article provides a detailed introduction to Rallybio Corp (RLYB), a clinical-stage biotechnology company focused on developing therapies for severe and rare diseases. It outlines the company's business scope, key pipeline assets like RLYB116, RLYB332, and RLYB114, and lists its financial data, market performance, …

Rallybio Market Sentiment

This article provides an overview of market sentiment for Rallybio (RLYB), including an "Outperform" analyst consensus from 7 analysts with an average price target of $9, which is 44.3% below the current trading price. The company's short interest is 8.3% and declining, which is …

Rallybio Corporation (NASDAQ:RLYB) Sees Significant Decline in Short Interest

Rallybio Corporation (NASDAQ:RLYB) experienced a significant 58.4% decrease in short interest by July 15th, bringing the total to 170,156 shares. Despite insider buying, institutional ownership is high at 90.34%, and the company remains unprofitable with a consensus "Sell" rating. The stock opened at $16.31, …

RLYB Financials

This article provides a detailed financial overview of Rallybio Corp (RLYB), including its income statement, balance sheet, and cash flow statement. It highlights key financial indicators such as EPS, revenue, net profit, and various margins over several quarters and fiscal years. The report also …

Rallybio Corp (RLYB) Institutional Confidence

Rallybio Corp (RLYB) has an institutional shareholding score of 5.00, placing it 132nd out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 65.82%, a slight decrease of 1.97% quarter-over-quarter. Andreas Halvorsen is the largest institutional shareholder, holding …

LyondellBasell Industries NV Revenue Breakdown – NYSE:LYB

Rallybio Corp (RLYB) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Rallybio Corp (RLYB), detailing its current price momentum score, support and resistance levels, and a comprehensive breakdown of technical indicators and moving averages. The analysis suggests a "Neutral" signal for the stock based on these indicators, noting …

LyondellBasell (LYB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Wall Street expects a year-over-year increase in earnings on higher revenues when LyondellBasell (LYB) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock …

What to Expect From LyondellBasell Industries’ Q2 2026 Earnings Report

Advertisement billboard displaying logo of LyondellBasell Indust By monticellllo With a market cap of $20.1 billion, LyondellBasell Industries N.V. (LYB) is one of the world's largest chemical and plastics manufacturers, producing materials used in packaging, automotive, construction, consumer goods, healthcare, and industrial applications. The …

LYB: LyondellBasell Industries NV - Ordinary Shares - Class A Latest Stock Price, Analysis, News and Trading Ideas

This article provides the latest stock information for LyondellBasell Industries NV (LYB), including its current stock price, market capitalization, volume, and yearly highs and lows. It also highlights recent news articles concerning LYB, such as its partnership with Mondelez and an upcoming Q2 earnings …

LyondellBasell: Buying Opportunity Before Huge Earnings (NYSE:LYB)

Understanding the Setup: (LYB) and Scalable Risk

This article analyzes Lyondellbasell Industries (LYB), highlighting a strong overweight bias across all time horizons. It details an exceptional 69.2:1 risk-reward setup targeting a 19.9% gain against a 0.3% risk. The piece also outlines three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific …

RLYB Stock Hits 2-Year Highs After Unveiling Merger With Avenzo – How Much Of The New Company Will Rallybio Shareholders Own?

Century Plyboards reports record revenue in Q4FY26

Rallybio Corporation Q1 2026 Earnings: Wider Loss Reflects R&D Investment, Stock Gains - Forward Guidance Trends

Century Plyboards' net profit rises 44.20% to ₹268.33 crore in FY26

Century Ply Q4 profit jumps 49% as revenue hits record high on strong plywood and laminates demand

Century Plyboards Q3 Results: Net profit rises 9%, margin at 12.6%

Century Plyboards Reports Strong Q3FY26 Results; Revenue Grows 18% YoY

Rallybio reverse split swaps 8 shares for 1, cash for fractions

Century Plyboards India Ltd Schedules Board Meeting for February 4, 2026 to Review Q3FY26 Financial Results

Century Plyboards (India) Ltd. Share Price Live Today

Century Plyboards (India) Q4 Results

Century Plyboards (India) Limited's (NSE:CENTURYPLY) CEO Compensation Is Looking A Bit Stretched At The Moment

Century Plyboards (India) (NSE:CENTURYPLY) Will Pay A Dividend Of ₹1.00

Century Ply Sets Ambitious ₹5,000 Crore Revenue Target for FY28